Trends in incidence and survival of cutaneous malignant melanoma in Estonia: a population-based study

References

• Christensen KG, Fenger-Gron M, Flarup KR, et al. Use of general practice, diagnostic investigations and hospital services before and after cancer diagnosis: a population-based nationwide registry study of 127,000 incident adult cancer patients. BMC Health Serv Res 2012;12:224.
   PubMed Web of Science ®Google Scholar
• Innos K, Baburin A, Aareleid T. Cancer patient survival in Estonia 1995-2009: time trends and data quality. Cancer Epidemiol 2014;38:253–8.
   PubMed Web of Science ®Google Scholar
• Sant M, Aareleid T, Berrino F, et al. EUROCARE-3: survival of cancer patients diagnosed 1990-94-results and commentary. Ann Oncol 2003;14 Suppl 5:v61–118.
   PubMed Web of Science ®Google Scholar
• Crocetti E, Mallone S, Robsahm TE, et al. Survival of patients with skin melanoma in Europe increases further: Results of the EUROCARE-5 study. Eur J Cancer 2015;51:2179–90.
   PubMed Web of Science ®Google Scholar
• Innos K, Padrik P, Valvere V, et al. Sex differences in cancer survival in Estonia: a population-based study. BMC Cancer 2015;15:72.
   PubMed Web of Science ®Google Scholar
• Balch CM, Soong SJ, Atkins MB, et al. An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin 2004;54:131–49.
   PubMed Web of Science ®Google Scholar
• Homsi J, Kashani-Sabet M, Messina JL, et al. Cutaneous melanoma: prognostic factors. Cancer Control 2005;12:223–9.
   PubMedGoogle Scholar
• Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009;27:6199–206.
   PubMed Web of Science ®Google Scholar
• Ederer F, Heise H, Instructions to IBM 650 programmers in processing survival computations. Methodological note no. 10. Bethesda: End Results Evaluation Section, National Cancer Institute; 1959.
   Google Scholar
• Brenner H, Rachet B. Hybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident cases. Eur J Cancer 2004;40:2494–501.
   PubMed Web of Science ®Google Scholar
• Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 2004;40:2307–16.
   PubMed Web of Science ®Google Scholar
• Dickman PW, Coviello E. Estimating and modeling relative survival. Stata J 2015;15:186–215.
   Web of Science ®Google Scholar
• Godar DE. Worldwide increasing incidences of cutaneous malignant melanoma. J Skin Cancer 2011;2011:858425.
   PubMedGoogle Scholar
• Wallingford SC, Alston RD, Birch JM, et al. Increases in invasive melanoma in England, 1979-2006, by anatomical site. Br J Dermatol 2011;165:859–64.
   PubMed Web of Science ®Google Scholar
• Leiter U, Garbe C. Epidemiology of melanoma and nonmelanoma skin cancer-the role of sunlight. Adv Exp Med Biol 2008;624:89–103.
   PubMed Web of Science ®Google Scholar
• Thompson JF, Scolyer RA, Kefford RF. Cutaneous melanoma. Lancet 2005;365:687–701.
   PubMed Web of Science ®Google Scholar
• Tekkel M, Veideman T, Health behavior among Estonian adult population, 2014. Tallinn: National Institute for Health Development; 2015.
   Google Scholar
• Engholm G, Ferlay J, Christensen N, et al. NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 7.2 (16.12.2015). Association of the Nordic Cancer Registries. Danish Cancer Society; 2016. Available from: http://www.ancr.nu/ [last accessed on 02/05/2016: Danish Cancer Society].
   Google Scholar
• Buettner PG, Leiter U, Eigentler TK, et al. Development of prognostic factors and survival in cutaneous melanoma over 25 years: an analysis of the Central Malignant Melanoma Registry of the German Dermatological Society. Cancer 2005;103:616–24.
   PubMed Web of Science ®Google Scholar
• Bay C, Kejs AM, Storm HH, et al. Incidence and survival in patients with cutaneous melanoma by morphology, anatomical site and TNM stage: a Danish Population-based Register Study 1989-2011. Cancer Epidemiol 2015;39:1–7.
   PubMed Web of Science ®Google Scholar
• Lyth J, Eriksson H, Hansson J, et al. Trends in cutaneous malignant melanoma in Sweden 1997-2011: thinner tumours and improved survival among men. Br J Dermatol 2015;172:700–6.
   PubMed Web of Science ®Google Scholar
• De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study. Lancet Oncol 2014;15:23–34.
   PubMed Web of Science ®Google Scholar
• Crocetti E, Fancelli L, Manneschi G, et al. Melanoma survival: sex does matter, but we do not know how. Eur J Cancer Prev 2016;25:404–9.
   PubMed Web of Science ®Google Scholar
• Nosrati A, Wei ML. Sex disparities in melanoma outcomes: the role of biology. Arch Biochem Biophys 2014;563:42–50.
   PubMed Web of Science ®Google Scholar
• Kelly JW. Melanoma in the elderly – a neglected public health challenge. Med J Aust 1998;169:403–4.
   PubMed Web of Science ®Google Scholar
• Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001;19:3622–34.
   PubMed Web of Science ®Google Scholar